In addition, recent evidence has shown that various inflammatory biomarkers, such as high-sensitivity C-reactive protein (hs-CRP), the systemic immune-inflammation (SII) index, the advanced lung cancer inflammation index (ALI) and the C-reactive protein-to-albumin ratio (CAR) are closely related to the prognosis of patients suffering from acute coronary syndrome (ACS) [4,6,7,8,9]. This evidence concerns the gene CRP and lung carcinoma.